SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-16
👔
Vaxcyte, Inc.
@PCVX_InsiderForm 4 Filing: Markels John Acquires (Grant) shares of $PCVX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Vaxcyte, Inc.
Ticker: $PCVX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-16
Shares: 23,029
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Markels John, holds the title of Director at Vaxcyte, Inc..
On 2026-07-16, the insider transacted 23,029 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Markels John (Director) was granted $0 of $PCVX
Post-Transaction Position: 23,029 shares
SEC Accession No: 0001803424-26-000004 (CIK: 1803424)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.